Skip to main content
SpringerLink
Log in

Etretinate therapy in children with severe keratinization defects

  • Review
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Keratinization defects can be very severe and disfiguring diseases. The development of retinoids such as etretinate has provided us with an effective symptomatic form of oral therapy for these skin conditions. Based on our own experience, we briefly outline the therapeutic potential of etretinate in various keratinization defects (lamellar ichthyosis, Netherton syndrome, Sjögren-Larsson syndrome, mal de Meleda and juvenile pityriasis rubra pilaris). The toxicology of etretinate is reviewed with special regard to the treatment of children. Bone changes such as premature closure of the growth line or other unacceptable side-effects have so far not been observed. Guidelines for patient selection and for the safe treatment of children are given.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bauer EA, Seltzner JL, Eisen AZ (1983) Retinoic acid inhibition of collagenase and gelatinase expression in human skin fibroblast cultures. Evidence for a dual mechanism. J Invest Dermatol 81:162–169

    Google Scholar 

  2. Blanchet-Bardon C, Anton-Lamprecht I, Schnyder UW (1977) Erythrodermie congénitale ichtyosiforme bulleuse. Contrôle ultrastructural du traitement par l'éther éthylique d'un dérivé aromatique de l'acide rétinoique. Ann Dermatol Venercol 104: 648–653

    Google Scholar 

  3. Bravo-Piris J, Aparicio M, Moran M, Armijo M (1983) Papillon-Lefèvre syndrome. Report of a case treated with oral retinoid Ro 10-9359. Dermatologica 166:97–103

    Google Scholar 

  4. DiGiovanna JJ, Peck GL (1983) Oral synthetic retinoid treatment in children. Pediatr Dermatol 1:77–88

    Google Scholar 

  5. Ellis CN, Madison KC, Pennes DR, Martel W, Voorhees JJ (1984) Isotretinoin therapy is associated with early skeletal radiographic changes. J Am Acad Dermatol 10:1024–1029

    Google Scholar 

  6. Fleissner J, Happle R (1981) Etretinate in the treatment of juvenile pityriasis rubra pilaris. Arch Dermatol 117:749–750

    Google Scholar 

  7. Frenk E (1981) Traitement oral de l'ichtyose lamellaire (erythrodermie ichtyosiforme congénitale non bulleuse) avec un rétinoide aromatique. Etude clinique, microscopique optique et électronique d'un essai thérapeutique de plus de 2 ans. Dermatologica 162:91–103

    Google Scholar 

  8. Gollnick H, Luley C, Schwartzkopff W, Orfanos CE (1982) Veränderungen von Serumlipidfraktionen als Nebenwirkung oraler Retinoide. Z Hautkr 57:1255–1267

    Google Scholar 

  9. Happle R, Niedworok A (1981) Cytogenetic studies in patients treated with oral retinoid Ro 10-9359. In: Orfanos CE, Braun-Falco O, Farber EM, Grupper Ch, Polano MK, Schuppli R (eds) Retinoids. Advances in basic research and therapy. Springer, Berlin, pp 61–65

    Google Scholar 

  10. Happle R, Traupe H (1984) Etretinat bei Genodermatosen und verschiedenen entzündlichen Hautkrankheiten. In: Bauer R, Gollnick H (eds) Retinoide in der Praxis. Grosse, Berlin, pp 35–49

    Google Scholar 

  11. Happle R, Traupe H, Bounameaux Y, Fisch T (1984) Teratogene Wirkung von Etretinat beim Menschen. Dtsch Med Wochenschr 109:1476–1480

    Google Scholar 

  12. Hintner H, Jaschke E, Fritsch P (1980) Netherton-Syndrom: Abwehrschwäche, generalisierte Verrukose und Karzinogenese. Hautarzt 31:428–432

    Google Scholar 

  13. Hummler H, Schüpbach ME (1981) Studies in reproductive toxicology and mutagenicity with Ro 10-9359. In: Orfanos CE, Braun-Falco O, Farber EM, Grupper Ch, Polano MK, Schuppli R (eds) Retinoids. Advances in basic research and therapy. Springer, Berlin, pp 49–59

    Google Scholar 

  14. Jagell S, Lidén S (1982) Treatment of the ichthyosis of the Sjögren-Larsson syndrome with etretinate (Tigason). Acta Dermatovenereol 63:89–91

    Google Scholar 

  15. Miescher G (1954) Behandlung der Ichthyosis mit Vitamin A. Dermatologica 108:300–303

    Google Scholar 

  16. Milstone LM, McGuire J, Ablow RC (1982) Premature epiphyseal closure in a child receiving oral 13-cis-retinoic acid. J Am Acad Dermatol 7:663–666

    Google Scholar 

  17. Obe G, Tsambaos D (1981) Chromosomal analysis in patients treated with the oral aromatic retinoid Ro 10-9359. In: Orfanos CE, Braun-Falco O, Farber EM, Grupper Ch, Polano MK, Schuppli R (eds) Retinoids. Advances in basic research and therapy. Springer, Berlin, pp 67–70

    Google Scholar 

  18. Orfanos CE, Mahrle G, Goerz G, Happle R, Hofbauer M, Landes E, Schimpf A (1979) Laboratory investigations in patients with generalized psoriasis under oral retinoid treatment. A multi-center study of computerized data. Dermatologica 159:62–70

    Google Scholar 

  19. Paravicini U (1981) Pharmacokinetics and metabolism of oral aromatic retinoids. In: Orfanos CE, Braun-Falco O, Farber EM, Grupper Ch, Polano MK, Schuppli R (eds) Retinoids. Advances in basic research and therapy. Springer, Berlin, pp 13–20

    Google Scholar 

  20. Pehamberger H, Esca SA, Holubar K (1979) Behandlung hyperkeratotischer Dermatosen mit einem oralen, aromatischen Retinoid (Ro 10-9359). Z Hautkr 55:68–78

    Google Scholar 

  21. Pittsley RA, Yoder FA (1983) Retinoid hyperostosis. Skeletal toxicity associated with long-term administration of 13-cis retinoic acid for refractory ichthyosis. New Engl J Med 308:1012–1014

    Google Scholar 

  22. Randazzo SD, Presti VL, Caruso A (1981) A proposal for computing the dosage of the aromatic retinoid Ro 10-9359 in relation to skin surface. In: Orfanos CE, Braun-Falco O, Farber EM, Grupper Ch, Polano MK, Schuppli R (eds) Retinoids. Advances in basic research and therapy. Springer, Berlin, pp 371–374

    Google Scholar 

  23. Schimpf A (1976) Zur systemischen Anwendung eines aromatischem Vitamin-A-Säure-Derivates (Ro 10-9359) bei Psoriasis und Keratosen. Z Hautkr 51:265–274

    Google Scholar 

  24. Schnyder UW, Vogel A (1980) Zur Behandlung der Erythrodermia congenitalis ichthyosiformis bullosa mit aromatischen Retinoiden. Aktuel Dermatol 6:133–136

    Google Scholar 

  25. Schroeff van der JG, Suurmond D (1981) Treatment of erythrokeratodermia variabilis with oral retinoid (Ro 10-9359). In: Orfanos CE, Braun-Falco O, Farber EM, Grupper Ch, Polano MK, Schuppli R (eds) Retinoids. Advances in basic research and therapy. Springer, Berlin, pp 295–301

    Google Scholar 

  26. Stüttgen G (1962) Zur Lokalbehandlung von Keratosen mit Vitamin A-Säure. Dermatologica 124:65–80

    Google Scholar 

  27. Tamayo L, Ruiz-Maldonado R (1981) Long-term follow-up of 30 children under oral retinoid Ro 10-9359. In: Orfanos CE, Braun-Falco O, Farber EM, Grupper Ch, Polano MK, Schuppli R (eds) Retinoids. Advances in basic research and therapy. Springer, Berlin, pp 287–294

    Google Scholar 

  28. Teelmann K (1981) Experimental toxicology of the aromatic retinoid Ro 10-9359 (etretinate). In: Orfanos CE, Braun-Falco O, Farber EM, Grupper Ch, Polano MK, Schuppli R (eds) Retinoids. Advances in basic research and therapy. Springer, Berlin, pp 41–47

    Google Scholar 

  29. Van der Rhee HJ, van Gelderen HH, Polano MK (1980) Is the use of Ro 10-9359 (Tigason) in children justified? Acta Dermatovenereol 60:274–275

    Google Scholar 

  30. Wehrmann W, Traupe H, Happle R (1984) Papillon-Lefèvre-Syndrom (Keratosis palmoplantaris mit Periodontopathie): Behandlung mit Etretinat. Hautarzt 35: in press

Download references

Author information

Authors and Affiliations

  1. Universitäts-Hautklinik, Von-Esmarch-Str. 56, D-4400, Münster, Germany

    Heiko Traupe & Rudolf Happle

Authors
  1. Heiko Traupe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rudolf Happle
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Dedicated to Prof. W. Lenz on the occasion of his 65th birthday

Rights and permissions

Reprints and permissions

About this article

Cite this article

Traupe, H., Happle, R. Etretinate therapy in children with severe keratinization defects. Eur J Pediatr 143, 166–169 (1985). https://doi.org/10.1007/BF00442128

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00442128

Key words

Search

Navigation